Precision Medicine Group was founded in 2012 to transform the process of bringing new drugs to market by integrating science, technology, data, and human expertise. We invest organically and acquire capabilities to address the fundamental changes in healthcare necessary for global health and outcomes improvement.
Guiding us with clear standards as we build a company that truly changes lives.
MARK P. CLEIN
ETHAN D. LEDER
To learn more about our leaders, please visit our websites.
For more information, or to learn how to change your cookies preferences, please click here.